Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-22-023367

Sr. VP, New Product Dev. gave up 498 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Kieffer Tara Lynn · Sr. VP, New Product Dev.

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-12-01 Shares withheld for taxes : show line 1 in the form −498 $44.33 $22,076 25,866 D
Loading xslF345X03/form4.xml…